St. John's wort and depression
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 70 (26) , 3077-3096
- https://doi.org/10.1016/s0024-3205(02)01566-7
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Variability in the Content of the Constituents ofHypericum perforatumL. and Some Commercial ExtractsDrug Development and Industrial Pharmacy, 2001
- Safety of St John's wort (Hypericum perforatum)The Lancet, 2000
- Herb-drug interactionsPublished by Elsevier ,2000
- Hypericum for depression: An update of the clinical evidenceEuropean Neuropsychopharmacology, 1999
- Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals σ receptor bindingLife Sciences, 1998
- Efficacy and Tolerability of St. John's Wort Extract LI 160 Versus Imipramine in Patients with Severe Depressive Episodes According to ICD-10Pharmacopsychiatry, 1997
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- Comparative Study of Cerebral Ventricular Dilation and Cognitive Function in Patients with Alzheimer's Disease of Early versus Late OnsetJournal of Geriatric Psychiatry and Neurology, 1994
- Valproate in the Treatment of Posttraumatic Bipolar Disorder in a Psychogeriatric PatientJournal of Geriatric Psychiatry and Neurology, 1994
- Reliability and Validity of the Short Portable Mental Status Questionnaire Administered by TelephoneJournal of Geriatric Psychiatry and Neurology, 1994